Affiliation:
1. FSBI «Zakusov Institute of Pharmacology»
Abstract
The effect of picamilon (50 mg/kg/day), tropoxin (10 mg/kg/day) and LK-933 (9,3 mg/kg/day) on the behavior of CD-1 mice phenotypes with different attention stability in the "closed enriched cross maze" test after 6 days of intraperitoneal administration was studied. It was shown for the first time that in mice with native attention deficit drugs with nootropic and cerebrovascular activity improved attention. Observed effect was combined with changings of exploratory behavior parameters, motor activity and anxiety in both mice subpopulations. Obtained results allow to make an assumption about further experimental study of drugs with cerebrovascular properties in the attention deficit disorder model proposed by the authors.
Subject
Pharmacology (medical),Complementary and alternative medicine,Pharmaceutical Science
Reference18 articles.
1. Mubarakshina AR. Asphyxia as a risk factor of attention deficit and hyperactivity disorder in children. Ros Vestn Perinatol Pediat. 2007;(6):67-72 (In Russ).].
2. Gribanov AV, Melkova LA, Fedotov DM. Cerebral hemodynamics in children aged 11-14 years with attention deficit hyperactivity disorder. Vestnik Severnogo (Arkticheskogo) federal'nogo universiteta. Ser.: Mediko-biologicheskie nauki, 2014;(3):16-26 (In Russ).].
3. Melkova LA, Fedotov DM, Bagretsova TV Comparative analysis of cerebral blood flow in 7-14-year-old children with attention deficit hyperactivity disorder. Vestnik Severnogo (Arkticheskogo) federal'nogo universiteta. Ser.: Mediko-biologicheskie nauki, 2014;(4):39-50. (In Russ).].
4. Kovalev GI, Salimov RM, Sukhorukova NA, et al. Neuroreceptor profile and behavior of CD-1 mice subpopulations with different attention stability. Neurochemical Journal. 2020;37(1):15-23. (In Russ).]. DOI: 10.1134/S1819712420010146.
5. Kovalev GI, Sukhorukova NA, Vasil'eva EV, et al. Influence of pantogam and atomoxetine on attention stability and distribution of dopamine D2 and GABAB receptors in the attention deficit mouse model. Biomeditsinskaya khimiya. 2021;67(5):402-410 (In Russ).]. DOI: 10.18097/PBMC20216705402.